Author:
Rudek Michelle A.,Venitz Jürgen,Ando Yuichi,Reed Eddie,Pluda James M.,Figg William D.
Subject
Pharmacology (medical),Pharmacology
Reference46 articles.
1. Development of matrix metalloproteinase inhibitors in cancer therapy;Hidalgo;J Natl Cancer Inst,2001
2. Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer;Rudek;J Clin Oncol,2001
3. Degradation kinetics of 4-dedimethylamino sancycline, a new anti-tumor agent, in aqueous solutions;Pinsuwan;Int J Pharm,1999
4. Evidence for dissolution rate-limited absorption of COL-3, a matrix metalloproteinase inhibitor, leading to the irregular absorption profile in rats after oral administration;Li;Pharm Res,2002
5. Metabolism of minocycline in humans;Nelis;Drug Metab Dispos,1982
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献